BR0009782A - Preparo de moléculas biologicamente ativas - Google Patents
Preparo de moléculas biologicamente ativasInfo
- Publication number
- BR0009782A BR0009782A BR0009782-9A BR0009782A BR0009782A BR 0009782 A BR0009782 A BR 0009782A BR 0009782 A BR0009782 A BR 0009782A BR 0009782 A BR0009782 A BR 0009782A
- Authority
- BR
- Brazil
- Prior art keywords
- biologically active
- active molecules
- preparation
- molecule
- biologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
Patente de Invenção: "PREPARO DE MOLéCULAS BIOLOGICAMENTE ATIVAS". Moléculas biologicamente ativas são produzidas a partir de seus precursores biologicamente inativos através de mutação de seu local de clivagem nativo a um local o qual é capaz de ser clivado por uma protease e clivagem da molécula que sofreu mutação a fim de proporcionar uma molécula biologicamente ativa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12942799A IL129427A0 (en) | 1999-04-13 | 1999-04-13 | Preparation of biologically active molecules |
PCT/IL2000/000220 WO2000061768A2 (en) | 1999-04-13 | 2000-04-13 | Preparation of biologically active molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009782A true BR0009782A (pt) | 2002-01-08 |
Family
ID=11072700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009782-9A BR0009782A (pt) | 1999-04-13 | 2000-04-13 | Preparo de moléculas biologicamente ativas |
Country Status (24)
Country | Link |
---|---|
US (1) | US7098002B1 (pt) |
EP (1) | EP1169460B1 (pt) |
JP (1) | JP4822587B2 (pt) |
KR (1) | KR100682185B1 (pt) |
CN (1) | CN1324140C (pt) |
AR (1) | AR023468A1 (pt) |
AT (1) | ATE326536T1 (pt) |
AU (1) | AU781342B2 (pt) |
BR (1) | BR0009782A (pt) |
CA (1) | CA2368994C (pt) |
DE (1) | DE60028022T2 (pt) |
DK (1) | DK1169460T3 (pt) |
EA (1) | EA006825B1 (pt) |
EE (1) | EE05591B1 (pt) |
ES (1) | ES2259287T3 (pt) |
HK (1) | HK1044351A1 (pt) |
IL (3) | IL129427A0 (pt) |
MX (1) | MXPA01010487A (pt) |
NO (1) | NO329525B1 (pt) |
PT (1) | PT1169460E (pt) |
SI (1) | SI1169460T1 (pt) |
UA (1) | UA73940C2 (pt) |
WO (1) | WO2000061768A2 (pt) |
ZA (1) | ZA200108364B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001029232A2 (en) * | 1999-10-20 | 2001-04-26 | Scios Inc. | Functional cloning of genes encoding proteins/enzymes involved in proteolytic cleavage |
US7273722B2 (en) | 2000-11-29 | 2007-09-25 | Allergan, Inc. | Neurotoxins with enhanced target specificity |
SI1392830T1 (sl) | 2001-03-08 | 2006-06-30 | Ares Trading Sa | Mutanti interlevkina-18, njihova proizvodnja in uporaba |
IL142246A0 (en) * | 2001-03-26 | 2002-03-10 | Applied Research Systems | Method and kit for quantitation of polypeptides |
WO2003068802A2 (en) | 2002-02-11 | 2003-08-21 | Zymogenetics, Inc. | Materials and methods for preparing dimeric growth factors |
WO2004074488A1 (en) * | 2003-02-21 | 2004-09-02 | Biotecnol S.A. | Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
US7824885B2 (en) * | 2003-08-06 | 2010-11-02 | University Of Maryland, College Park | Engineered proteases for affinity purification and processing of fusion proteins |
JP2007512008A (ja) * | 2003-11-24 | 2007-05-17 | ノボ ノルディスク アクティーゼルスカブ | 融合タンパク質及び該タンパク質の切断方法 |
CA2558811A1 (en) | 2004-03-08 | 2005-09-22 | Zymogenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
WO2008008082A2 (en) * | 2005-09-19 | 2008-01-17 | Allergan, Inc. | Clostridial toxin activatable clostridial toxins |
EP2014676B1 (en) * | 2006-04-20 | 2012-03-07 | Kringle Pharma Inc. | Hgf precursor protein mutant and activated form thereof |
DE102007008596B4 (de) * | 2007-02-15 | 2010-09-02 | Friedrich-Schiller-Universität Jena | Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung |
CA3128656A1 (en) | 2007-08-22 | 2009-02-26 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
WO2009044988A1 (en) * | 2007-10-01 | 2009-04-09 | Korea Research Institute Of Bioscience And Biotechnology | Method for large scale preparation of procaspases, which can be artificially activated, in e. coli expression system and their activation |
DE102009043743B4 (de) | 2009-03-13 | 2016-10-13 | Friedrich-Schiller-Universität Jena | Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung |
RU2636046C2 (ru) | 2009-01-12 | 2017-11-17 | Сайтомкс Терапьютикс, Инк | Композиции модифицированных антител, способы их получения и применения |
EP2398494A4 (en) | 2009-02-23 | 2015-10-28 | Cytomx Therapeutics Inc | Proproteins and their methods of use |
CN103923897B (zh) * | 2013-01-11 | 2016-06-01 | 中国人民解放军军事医学科学院生物工程研究所 | caspase重组酶原及其编码基因与应用 |
CN103388001B (zh) * | 2013-07-16 | 2016-01-20 | 中国人民解放军第四军医大学 | 一种含凝血酶切割位点gst膜型表达载体及转染阳性细胞的方法 |
EP3083977B1 (en) | 2013-12-20 | 2018-02-28 | F. Hoffmann-La Roche AG | Improved recombinant polypeptide production methods |
KR20230048162A (ko) | 2015-03-30 | 2023-04-10 | 그린라이트 바이오사이언시스, 아이엔씨. | 리보핵산의 무세포 생산 |
IL302486A (en) | 2015-06-24 | 2023-06-01 | Hoffmann La Roche | Antibodies against the transnephrine receptor with adapted affinity |
PE20231655A1 (es) | 2015-10-02 | 2023-10-17 | Hoffmann La Roche | Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso |
AR106189A1 (es) | 2015-10-02 | 2017-12-20 | Hoffmann La Roche | ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO |
WO2017176963A1 (en) | 2016-04-06 | 2017-10-12 | Greenlight Biosciences, Inc. | Cell-free production of ribonucleic acid |
MX2020003841A (es) | 2017-10-11 | 2020-11-06 | Greenlight Biosciences Inc | Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos. |
KR20200080749A (ko) * | 2018-12-27 | 2020-07-07 | 주식회사 폴루스 | N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법 |
EP4013857A1 (en) * | 2019-08-13 | 2022-06-22 | King's College London | Immunoresponsive cells armoured with spatiotemporally restricted activity of cytokines of the il-1 superfamily |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824297A (en) * | 1990-06-25 | 1998-10-20 | Oncogene Science, Inc. | Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
AU659412B2 (en) * | 1990-06-25 | 1995-05-18 | Osi Pharmaceuticals, Inc. | Tissue-derived tumor growth inhibitors |
EP0533350B1 (en) * | 1991-08-16 | 1999-05-26 | Merck & Co. Inc. | DNA encoding precursor interleukin 1B converting enzyme |
JP3404038B2 (ja) | 1991-12-31 | 2003-05-06 | ザイモジェネティクス,インコーポレイティド | トロンビンの製造方法 |
JPH06125784A (ja) * | 1992-01-17 | 1994-05-10 | Takeda Chem Ind Ltd | モノクローナル抗体,ハイブリドーマ,その製造法および用途 |
US6303369B1 (en) * | 1993-09-30 | 2001-10-16 | Carl Spana | Protein expression system |
JP2000502903A (ja) | 1995-12-29 | 2000-03-14 | インサイト・ファーマスーティカルズ・インコーポレイテッド | インターフェロンγ誘導因子―2をコードする核酸 |
JP4059941B2 (ja) * | 1996-08-26 | 2008-03-12 | 社団法人芝蘭会 | Rho標的タンパク質p140mDia |
AT405516B (de) * | 1997-02-27 | 1999-09-27 | Immuno Ag | Faktor x-analoge mit modifizierter proteasespaltstelle |
JPH10327872A (ja) * | 1997-05-30 | 1998-12-15 | Otsuka Pharmaceut Co Ltd | Bcl−2相互作用蛋白遺伝子bis |
CA2295957C (en) | 1997-08-07 | 2009-09-22 | Toray Industries, Inc. | Canine interleukin 18, canine interleukin 1.beta. converting enzyme, dna sequences encoding these, interleukin 18 production method and canine immune disease remedy |
-
1999
- 1999-04-13 IL IL12942799A patent/IL129427A0/xx unknown
-
2000
- 2000-04-12 AR ARP000101692A patent/AR023468A1/es not_active Application Discontinuation
- 2000-04-13 ES ES00919108T patent/ES2259287T3/es not_active Expired - Lifetime
- 2000-04-13 EE EEP200100530A patent/EE05591B1/xx not_active IP Right Cessation
- 2000-04-13 PT PT00919108T patent/PT1169460E/pt unknown
- 2000-04-13 SI SI200030860T patent/SI1169460T1/sl unknown
- 2000-04-13 MX MXPA01010487A patent/MXPA01010487A/es active IP Right Grant
- 2000-04-13 AT AT00919108T patent/ATE326536T1/de active
- 2000-04-13 AU AU39851/00A patent/AU781342B2/en not_active Ceased
- 2000-04-13 US US09/958,914 patent/US7098002B1/en not_active Expired - Fee Related
- 2000-04-13 BR BR0009782-9A patent/BR0009782A/pt active Search and Examination
- 2000-04-13 DE DE60028022T patent/DE60028022T2/de not_active Expired - Lifetime
- 2000-04-13 WO PCT/IL2000/000220 patent/WO2000061768A2/en active IP Right Grant
- 2000-04-13 JP JP2000611691A patent/JP4822587B2/ja not_active Expired - Fee Related
- 2000-04-13 IL IL14584200A patent/IL145842A0/xx active IP Right Grant
- 2000-04-13 EA EA200101078A patent/EA006825B1/ru not_active IP Right Cessation
- 2000-04-13 UA UA2001117751A patent/UA73940C2/uk unknown
- 2000-04-13 CN CNB008080577A patent/CN1324140C/zh not_active Expired - Fee Related
- 2000-04-13 CA CA002368994A patent/CA2368994C/en not_active Expired - Fee Related
- 2000-04-13 EP EP00919108A patent/EP1169460B1/en not_active Expired - Lifetime
- 2000-04-13 DK DK00919108T patent/DK1169460T3/da active
- 2000-04-13 KR KR1020017012973A patent/KR100682185B1/ko not_active IP Right Cessation
-
2001
- 2001-10-10 IL IL145842A patent/IL145842A/en not_active IP Right Cessation
- 2001-10-11 ZA ZA200108364A patent/ZA200108364B/en unknown
- 2001-10-12 NO NO20014966A patent/NO329525B1/no not_active IP Right Cessation
-
2002
- 2002-08-15 HK HK02105972A patent/HK1044351A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0009782A (pt) | Preparo de moléculas biologicamente ativas | |
Delaria et al. | Characterization of placental bikunin, a novel human serine protease inhibitor | |
BRPI0109131B8 (pt) | dna, vetor de expressão compreendendo o mesmo, fator viii modificado de porcino, seu processo de produção e composição terapêutica compreendendo o mesmo | |
BR0309576A (pt) | Variante de polipeptìdeo do fator vii (fvii) ou fator viia (fviia), sequência de nucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma variante, e, método para tratar um mamìfero que tenha uma doença ou um distúrbio em que a formação de coágulo é desejável | |
PE20060880A1 (es) | Conjugados de polipeptido y un pentasacarido que tienen propiedades farmacocineticas mejoradas | |
BR9406232A (pt) | Novo agente para controle da atividade celular | |
Hamamoto et al. | Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. | |
ATE279430T1 (de) | Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen | |
BR0010700A (pt) | Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata | |
BR0114475A (pt) | Célula para a produção de composição de anticorpo | |
BR9807627A (pt) | Análogo de fator x, dna recombinante codificante para um análogo de fator x, preparação contendo um análogo de fator x purificado ou uma sua proteìna precursora, preparação contendo análogo de fator xa apresentando alta estabilidade e integridade estrutural, usos de uma preparação e de um ácido nucleico, e, processos para a preparação de um preparado contendo análogo de fator x recombinante purificado, e para se preparar um preparado contendo fator xa ou análogo de fator xa ativos. | |
AR025754A1 (es) | Secretasa en la enfermedad de alzheimer, sustratos de la app y sus usos | |
CY1111006T1 (el) | Εκριμματαση ασθενειας alzheimer | |
BR9909129A (pt) | Conjugados de proteases | |
BRPI0411650A (pt) | variante polipeptìdica do fator vii (fvii) ou do fator viia (fviia), sequencia de nucleotìdeos , vetor de expressão, célula hospedeira, composição, uso de uma variante, e, método para tratar de um mamìfero tendo uma doença ou um distúrbio em que a formação de coágulo seja desejável | |
ATE411055T1 (de) | Verbesserungen für oder in bezug auf kontrastmittel | |
AU2001283353A1 (en) | Compositions containing hypoglycemically active stilbenoids | |
Rezaie | Exosite-dependent regulation of the protein C anticoagulant pathway | |
YU21399A (sh) | Konjugati koji sadrže delove rastvorljive u vodi, njihova upotreba u proizvodnji leka korisnog za tretiranje raka prostate i farmaceutske kompozicije koje ih sadrže | |
BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
BR9708553A (pt) | Processo para limpeza de um substrato e uso de umsistema ativador de oxigenio molecular | |
BR9911349A (pt) | Genes para a biossìntese de epotilonas | |
BR0112337A (pt) | Derivados de fosfolipìdeos de ácido valpróico e suas misturas | |
Amiconi et al. | A novel venombin B from Agkistrodon contortrix contortrix: evidence for recognition properties in the surface around the primary specificity pocket different from thrombin | |
PT1107996E (pt) | Anticorpos humanos anti-factor ix/ixa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 25 DA LPI. |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |